FDC Limited

NSE FDC.NS

FDC Limited Operating Income Margin for the year ending March 31, 2024: 15.68%

FDC Limited Operating Income Margin is 15.68% for the year ending March 31, 2024, a 31.88% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
  • FDC Limited Operating Income Margin for the year ending March 31, 2023 was 11.89%, a -16.18% change year over year.
  • FDC Limited Operating Income Margin for the year ending March 31, 2022 was 14.18%, a -36.48% change year over year.
  • FDC Limited Operating Income Margin for the year ending March 31, 2021 was 22.33%, a 11.73% change year over year.
  • FDC Limited Operating Income Margin for the year ending March 31, 2020 was 19.98%, a 9.62% change year over year.
Key data
Date Operating Income Margin EBT Margin Net Income Margin EBITDA Margin
Market news
Loading...
SV Wall Street
NSE: FDC.NS

FDC Limited

CEO Mr. Ameya Ashok Chandavarkar
IPO Date July 1, 2002
Location India
Headquarters C/3, Skyvistas
Employees 6,659
Sector Healthcare
Industries
Description

FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics, and others; and oral rehydration salts. It provides specialized formulations primarily under the Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm brand names. The company also offers anti-oxidants, balanced energy drinks, and vitamins and nutraceuticals under the Enerzal, Humyl, Mum Mum 1, Prosoyal, Simyl-LBW, Simyl-MCT, and Zefrich brands. In addition, it provides various active pharmaceutical ingredients. FDC Limited was founded in 1936 and is headquartered in Mumbai, India.

Similar companies

IPCALAB.NS

Ipca Laboratories Limited

USD 17.29

1.29%

APLLTD.NS

Alembic Pharmaceuticals Limited

USD 10.21

0.43%

ELGIEQUIP.NS

Elgi Equipments Limited

USD 6.41

2.51%

INDOCO.NS

Indoco Remedies Limited

USD 3.19

1.00%

JBCHEPHARM.NS

J. B. Chemicals & Pharmaceuticals Limited

USD 19.59

-0.12%

StockViz Staff

February 7, 2025

Any question? Send us an email